MedCost Clear Cost calculator

Drugs / Cobenfy

Cobenfy cost

xanomeline and trospium chloride · Bristol Myers Squibb. Every official price for Cobenfy, side by side, with who pays it.

Short answer

FDA approved Cobenfy (xanomeline and trospium chloride) on Sep 26, 2024. Bristol Myers Squibb lists Cobenfy at $1,887 per 30-day supply, as of October 2026 (when we checked; the page gives no date). Pharmacies paid an average of $30.12–$30.25 per capsule (NADAC, Oct 21, 2026). In 2024, Medicare Part D spent $2.7 million on Cobenfy, an average of $1,556.59 per prescription fill before rebates (CMS). In Medicare Part D, the yearly out-of-pocket limit is $2,100 in 2026 and $2,400 in 2027.512634

Source: FDA, Bristol Myers Squibb, CMS, data.medicaid.gov (NADAC) and Medicare.gov · checked Nov 15, 2026

Cobenfy: the official numbers, by situation

PriceAmountWhose price, and who it applies toDate
List price
per 30-day supply
$1,8871 Bristol Myers Squibb's price to wholesalers (WAC). Most people don't pay it directly. October 2026 (when we checked; the page gives no date)
Pharmacy cost (NADAC)
per capsule; a month depends on your dose
$30.12–$30.252 What pharmacies pay on average (CMS survey). Not a patient price. Oct 21, 2026

On Medicare drug coverage: 5,492 of 5,492 Part D plans list Cobenfy for 2027 (100%), and 53% of those require prior authorization, in CMS's formulary file published Oct 15, 2026.12 By year and tier

None of these is your price at the counter: that depends on how you pay. Details and sources for each number are further down.

FDA approval

Every official price

PriceAmountWhat it isDate
Maker's list price (WAC) $1,8871 Per 30-day supply. The price the maker charges wholesalers; most people do not pay it directly. October 2026 (when we checked; the page gives no date) (checked Oct 25, 2026)
Pharmacy acquisition cost (NADAC)
Cobenfy 100 mg-20 mg Capsule
$30.132 Per capsule. The national average price pharmacies pay to buy it. Oct 21, 2026
Pharmacy acquisition cost (NADAC)
Cobenfy 125 mg-30 mg Capsule
$30.252 Per capsule. The national average price pharmacies pay to buy it. Oct 21, 2026
Pharmacy acquisition cost (NADAC)
Cobenfy 50 mg-20 mg Capsule
$30.232 Per capsule. The national average price pharmacies pay to buy it. Oct 21, 2026
Pharmacy acquisition cost (NADAC)
Cobenfy Starter pack
$30.122 Per tablet or capsule in the pack. The national average price pharmacies pay to buy it. Oct 21, 2026

These are prices the drug company, Medicare and pharmacies use. What you pay depends on your coverage; see below.

What Medicare spent on Cobenfy in 2024

CMS publishes what Part D spent on each drug each year. Its spending is the gross drug cost, which includes what Medicare, the plan and the patient paid,7 and it does not reflect manufacturers' rebates.8 CMS lists Cobenfy in 2 rows; together they come to $2.7 million over 1,749 prescription fills, $1,556.59 per fill.

Medicare Part D, calendar year 2024 (CMS Medicare Part D Spending by Drug, checked Nov 15, 2026).

Product (as CMS lists it)Total spendingFillsPeoplePer fillPer person
Cobenfy $2.4 million6 1,539 961 $1,533.179 $2,455.3110
Cobenfy Starter Pack $0.4 million6 210 204 $1,728.189 $1,779.0110

These are totals and averages across everyone in Medicare who used the drug, not a price for one person. Averages per person depend on how long and how much each person used it.

How many Medicare Part D plans list Cobenfy

Every Medicare drug plan in CMS's formulary file (standalone drug plans and Medicare Advantage plans with drug coverage). A plan counts when its drug list has at least one form or strength. Matched by RxNorm code and checked against the FDA NDC Directory. Plan counts, not people; to see your own plan's rules use Medicare Plan Finder.

Plan yearPlans that list itPrior auth.Step therapyQuantity limitLowest tier (plans)
2026 5,496 of 5,49611
100%
3,0424665,234 tier 1: 161 · tier 2: 2 · tier 3: 55 · tier 4: 1,376 · tier 5: 3,882 · tier 6: 20
2027 5,492 of 5,49212
100%
2,9214225,315 tier 1: 123 · tier 2: 1 · tier 4: 1,006 · tier 5: 4,362
2026: CMS file 2026_20260916.zip, published Sep 23, 2026 · 2027: CMS file 2027_20261008.zip, published Oct 15, 2026.

Being on a plan's list is not a price: what you pay depends on the tier and your plan. Each plan can divide its tiers in different ways. What prior authorization, step therapy and tiers mean.

With Medicare

With commercial insurance or no insurance

Which drug, which dose, and whether to start, stop or switch are medical decisions. Ask your doctor or pharmacist.

Official sources for this page (12)
  1. “The Wholesale Acquisition Cost (WAC), also known as list price, is $1,887 for 30 days of COBENFY. However, the WAC may not reflect the price paid by customers.”
  2. “Out-of-pocket limit Yearly $2,100 (in 2026).”
    Medicare.gov: Medicare costs · as of Oct 23, 2026
  3. “Out-of-Pocket Threshold: $2,100 Out-of-Pocket Threshold: $2,400”
  4. “Cobenfy xanomeline and trospium chloride 9/26/2024 To treat schizophrenia”
  5. “Cobenfy: Tot_Spndng_2024 2359549.66, Tot_Clms_2024 1539, Tot_Benes_2024 961; Cobenfy Starter Pack: Tot_Spndng_2024 362917.98, Tot_Clms_2024 210, Tot_Benes_2024 204”
  6. “Drug spending metrics for Part D drugs are based on the gross drug cost, which represents total spending for the prescription claim, including Medicare, plan, and beneficiary payments.”
  7. “The Part D spending metrics do not reflect any manufacturers' rebates or other price concessions as CMS is prohibited from publicly disclosing such information.”
  8. “Part D drug spending divided by the number of prescription fills.”
  9. “Total Part D drug spending divided by the number of unique beneficiaries utilizing the drug during the benefit year.”

Did this page answer your question?